Financial Position - As of December 31, 2023, the trust account held a total of 5,613,395,including5,325,694 from the IPO and 287,701frominterestincome[118].−AsofDecember31,2023,theTrustAccountheldmarketablesecuritiestotaling5,613,395, including 287,701ofinterestincome[143].−CashheldoutsidetheTrustAccountforgeneralworkingcapitalpurposesamountedto16,089 as of December 31, 2023[145]. - The Company has no off-balance sheet financing arrangements as of December 31, 2023[152]. IPO and Transaction Costs - The company generated gross proceeds of 60,000,000fromtheInitialPublicOfferingof6,000,000Unitsat10.00 per Unit[140]. - The company incurred transaction costs of 5,090,361relatedtotheIPO,including1,380,000 in underwriting fees[141]. - The underwriters are entitled to a deferred fee of 2,070,000,payableonlyifaBusinessCombinationiscompleted[153].BusinessCombinationandCompliance−ThecompanyreceivedanoticefromNasdaqonDecember13,2023,regardingnon−compliancewiththe35,000,000 market value of listed securities requirement[119]. - The company regained compliance with the Nasdaq MVLS Rule on June 5, 2024, after maintaining a market value of 35,000,000orgreaterfor10consecutivebusinessdays[120].−ThecompanyextendedtheCombinationPeriodfromNovember16,2023,toFebruary16,2024,bydepositing51,932 into its trust account[130]. - The Company extended the deadline to complete its initial Business Combination from February 16, 2024, to May 16, 2024, by depositing 51,932intotheTrustAccount[149].−IfaBusinessCombinationisnotcompletedbyNovember16,2024,amandatoryliquidationwilloccur,raisingsubstantialdoubtabouttheCompany′sabilitytocontinueasagoingconcern[150].−Thecompanyenteredintoanon−bindingtermsheetwithCUBEBIOCo.,Ltd.foraproposedbusinesscombinationonMay2,2024[136].FinancialPerformance−FortheyearendedDecember31,2023,thecompanyreportedanetlossof2,251,116, with operating costs of 2,654,975andinterestincomeof510,728[138]. - The Company has withdrawn 129,288ofinterestearnedfromtheTrustAccountfortaxpaymentsand14,692,409 for redemptions[143]. - The Company does not have any dilutive securities as of December 31, 2023, resulting in diluted loss per share being the same as basic loss per share[156]. Debt and Notes - The company issued an unsecured promissory note of up to 400,000totheSponsoronOctober30,2023,forworkingcapitalpurposes[129].−Anon−interestbearingpromissorynoteof300,000 was issued to the Sponsor, which can be converted into 75,000 shares of Common Stock[146]. - As of December 31, 2023, there was an outstanding balance of 52,877onapromissorynotewithUHYAdvisors,with5,587 of interest accrued[147]. Revenue Generation - The company has not generated any operating revenues to date and does not expect to do so until after completing a Business Combination[138].